difference between tirzepatide and semiglutide vs Semaglutide: Weight Loss, Side Effects, Uses Trying to decide between semaglutide

Clinical trials show that Wegovy users lose about 15% of their body weight on average, while Mounjaro users may lose up to 20% at higher doses

Adults with Type 2 Diabetes or obesity-related conditions who have completed the standard two-month titration schedule (0.25mg to 0.5mg) and are ready for full maintenance therapy under ongoing medical supervision

Participants receiving the 2.4-mg weekly dose lost an average of 34 pounds over 68 weeks, compared to 6 pounds in the placebo groupa 15% reduction in body weight

STEP incluye 17 ensayos clnicos fase 3 en los que se espera incluir un total de 8.700 pacientes con sobrepeso u obesidad, con y sin comorbilidades

Physical function was measured at baseline and week 24 by assessing the time to rise from a chair 5 and 10 times and 4-meter gait speed, where gait speed was calculated as the average of 2 measurements at usual pace

Cox proportional hazards models were used to evaluate infection risks, with the proportional hazards assumption tested using the generalized Schoenfeld residuals method